Ugur SAHIN

Person

Mainz, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Coronavirus vaccine
- Patent number 12,208,136
- Issue date Jan 28, 2025
- BIONTECH SE
- Alexander Muik
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Enhancing the effect of CAR-engineered T cells by means of nucleic...
- Patent number 12,186,275
- Issue date Jan 7, 2025
- BioNTach Ceil & Gene Therapies GmbH and TRON—Translationaie Onkologie an der...
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Coronavirus vaccine
- Patent number 12,186,387
- Issue date Jan 7, 2025
- BIONTECH SE
- Alexander Muik
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for prediction of therapeutic efficacy of...
- Patent number 12,188,097
- Issue date Jan 7, 2025
- Astellas Pharma Inc.
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for stimulating immune response
- Patent number 12,168,051
- Issue date Dec 17, 2024
- BIONTECH SE
- Mahjoub Bihi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for predicting the usefulness of proteins or protein fragme...
- Patent number 12,153,041
- Issue date Nov 26, 2024
- TRON—Translationale Onkologie an der Universitatsmedizin der Johannes Gutenbe...
- Mathias Vormehr
- G01 - MEASURING TESTING
Information Patent Grant
Formulation for administration of RNA
- Patent number 12,150,947
- Issue date Nov 26, 2024
- BIONTECH SE
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coronavirus vaccine
- Patent number 12,133,899
- Issue date Nov 5, 2024
- BIONTECH SE
- Ugur Sahin
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Multispecific antibodies against CD40 and CD137
- Patent number 12,077,596
- Issue date Sep 3, 2024
- GENMAB A/S
- Isil Altintas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy involving antibodies against Claudin 18.2 for t...
- Patent number 12,059,464
- Issue date Aug 13, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilization of poly(A) sequence encoding DNA sequences
- Patent number 12,054,723
- Issue date Aug 6, 2024
- BIONTECH SE
- Florian Eberle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against claudin 18.2 useful in cancer diagnosis
- Patent number 11,976,130
- Issue date May 7, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RNA constructs and uses thereof
- Patent number 11,951,185
- Issue date Apr 9, 2024
- BIONTECH SE
- Ugur Sahin
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Multispecific antibodies against CD40 and CD137
- Patent number 11,939,388
- Issue date Mar 26, 2024
- GENMAB A/S
- Isil Altintas
- G01 - MEASURING TESTING
Information Patent Grant
Monoclonal antibodies directed against programmed death-1 protein a...
- Patent number 11,932,693
- Issue date Mar 19, 2024
- BIONTECH SE
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Coronavirus vaccine
- Patent number 11,925,694
- Issue date Mar 12, 2024
- BIONTECH SE
- Ugur Sahin
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Methods for characterizing loss of antigen presentation
- Patent number 11,920,194
- Issue date Mar 5, 2024
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies useful in cancer diagnosis
- Patent number 11,919,951
- Issue date Mar 5, 2024
- Astellas Pharma Inc.
- Rita Mitnacht-Kraus
- G01 - MEASURING TESTING
Information Patent Grant
Coronavirus vaccine
- Patent number 11,878,055
- Issue date Jan 23, 2024
- BIONTECH SE
- Alexander Muik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for reducing immunogenicity of RNA
- Patent number 11,873,478
- Issue date Jan 16, 2024
- BIONTECH SE
- Katalin Kariko
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic RNA
- Patent number 11,865,159
- Issue date Jan 9, 2024
- Sanofi
- Friederike Gieseke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific for claudin 6 (CLDN6)
- Patent number 11,858,988
- Issue date Jan 2, 2024
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies for treatment of cancer expressing claudin 6
- Patent number 11,859,008
- Issue date Jan 2, 2024
- GANYMED PHARMACEUTICALS GMBH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy involving antibodies against claudin 18.2 for t...
- Patent number 11,826,402
- Issue date Nov 28, 2023
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (C...
- Patent number 11,814,411
- Issue date Nov 14, 2023
- BIONTECH SE
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diagnosis and therapy of cancer involving cancer stem cells
- Patent number 11,795,218
- Issue date Oct 24, 2023
- BioNTech AG
- Ugur Sahin
- G01 - MEASURING TESTING
Information Patent Grant
Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2...
- Patent number 11,787,862
- Issue date Oct 17, 2023
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNA constructs and uses thereof
- Patent number 11,779,659
- Issue date Oct 10, 2023
- BIONTECH SE
- Ugur Sahin
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Monoclonal antibodies against Claudin-18 for treatment of cancer
- Patent number 11,739,139
- Issue date Aug 29, 2023
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for prediction of therapeutic efficacy of...
- Patent number 11,732,308
- Issue date Aug 22, 2023
- Astellas Pharma Inc.
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
METHODS AND COMPOSITIONS FOR PREDICTION OF THERAPEUTIC EFFICACY OF...
- Publication number 20250092469
- Publication date Mar 20, 2025
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR-MODIFIED CELLS FOR THE TREATMENT OF CLDN6...
- Publication number 20250025505
- Publication date Jan 23, 2025
- BIONTECH SE
- Ugur SAHIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNA ENCODING PEPTIDOGLYCAN HYDROLASE AND USE THEREOF FOR TREATING B...
- Publication number 20250027066
- Publication date Jan 23, 2025
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AGENTS ENCODING CLDN6 AND CD3 BINDING ELEMENTS FOR TREATING CLDN6-P...
- Publication number 20250009780
- Publication date Jan 9, 2025
- BIONTECH SE
- Ugur SAHIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABILIZATION OF POLY(A) SEQUENCE ENCODING DNA SEQUENCES
- Publication number 20250011797
- Publication date Jan 9, 2025
- BIONTECH SE
- Florian Eberle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION...
- Publication number 20250002600
- Publication date Jan 2, 2025
- GENMAB A/S
- Alexander MUIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TLR7 AGONIST AND COMBINATIONS FOR CANCER TREATMENT
- Publication number 20240415828
- Publication date Dec 19, 2024
- BIONTECH SE
- Ugur SAHIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC RNA FOR LUNG CANCER
- Publication number 20240415946
- Publication date Dec 19, 2024
- BIONTECH SE
- Ugur SAHIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION...
- Publication number 20240409653
- Publication date Dec 12, 2024
- GENMAB A/S
- Alexander MUIK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES TH...
- Publication number 20240400703
- Publication date Dec 5, 2024
- GENMAB A/S
- Kristel Kemper
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RNA CONSTRUCTS AND USES THEREOF
- Publication number 20240390524
- Publication date Nov 28, 2024
- BIONTECH SE
- Ugur Sahin
- B82 - NANO-TECHNOLOGY
Information Patent Application
VIRUS VACCINE
- Publication number 20240383947
- Publication date Nov 21, 2024
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES TH...
- Publication number 20240376221
- Publication date Nov 14, 2024
- GENMAB A/S
- Kristel Kemper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CORONAVIRUS VACCINE
- Publication number 20240366751
- Publication date Nov 7, 2024
- BIONTECH SE
- Alexander Muik
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SYSTEMS AND METHODS FOR DETECTION, MONITORING, AND INTERACTIVE DISP...
- Publication number 20240355417
- Publication date Oct 24, 2024
- BIONTECH SE
- Alexander Muik
Information Patent Application
TECHNOLOGIES FOR EARLY DETECTION OF VARIANTS OF INTEREST
- Publication number 20240339174
- Publication date Oct 10, 2024
- BIONTECH SE
- Alexander Muik
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPEUTIC RNA FOR TREATING CANCER
- Publication number 20240335511
- Publication date Oct 10, 2024
- BIONTECH SE
- Ugur SAHIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...
- Publication number 20240335533
- Publication date Oct 10, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC BINDING AGENTS AGAINST CD40 AND CD137 IN COMBINATION...
- Publication number 20240327544
- Publication date Oct 3, 2024
- BIONTECH SE
- Ugur SAHIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOGEN SELECTION
- Publication number 20240321387
- Publication date Sep 26, 2024
- BIONTECH SE
- Alexander Muik
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS
- Publication number 20240309108
- Publication date Sep 19, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- G01 - MEASURING TESTING
Information Patent Application
RNA REPLICON FOR EXPRESSING AT CELL RECEPTOR OR AN ARTIFICIAL T CEL...
- Publication number 20240287155
- Publication date Aug 29, 2024
- BIONTECH CELL & GENE THERAPIES GMBH
- Petra OEHM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR CHARACTERIZING LOSS OF ANTIGEN PRESENTATION
- Publication number 20240263232
- Publication date Aug 8, 2024
- BIONTECH SE
- Ugur SAHIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION DOSAGE REGIME OF CD137 AND PD-L1 BINDING AGENTS
- Publication number 20240262924
- Publication date Aug 8, 2024
- GENMAB A/S
- Ugur SAHIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONISTIC TNF RECEPTOR BINDING AGENTS
- Publication number 20240254249
- Publication date Aug 1, 2024
- BIONTECH SE
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Agents for Treatment of Claudin Expressing Cancer Diseases
- Publication number 20240228616
- Publication date Jul 11, 2024
- BIONTECH AG
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES USEFUL IN CANCER DIAGNOSIS
- Publication number 20240209079
- Publication date Jun 27, 2024
- Astellas Pharma Inc.
- Rita MITNACHT-KRAUS
- G01 - MEASURING TESTING
Information Patent Application
Therapeutic RNA
- Publication number 20240173382
- Publication date May 30, 2024
- SANOFI
- Friederike Gieseke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC TRIVALENT ANTIBODIES BINDING TO CLAUDIN6 OR CLAUDIN18.2...
- Publication number 20240158501
- Publication date May 16, 2024
- BIONTECH SE
- Ugur Sahin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER
- Publication number 20240117022
- Publication date Apr 11, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Coronavirus vaccine

Enhancing the effect of CAR-engineered T cells by means of nucleic...

Coronavirus vaccine

Methods and compositions for prediction of therapeutic efficacy of...

Methods and compositions for stimulating immune response

Methods for predicting the usefulness of proteins or protein fragme...

Formulation for administration of RNA

Coronavirus vaccine

Multispecific antibodies against CD40 and CD137

Combination therapy involving antibodies against Claudin 18.2 for t...

Stabilization of poly(A) sequence encoding DNA sequences

Antibodies against claudin 18.2 useful in cancer diagnosis

RNA constructs and uses thereof

Multispecific antibodies against CD40 and CD137

Monoclonal antibodies directed against programmed death-1 protein a...

Coronavirus vaccine

Methods for characterizing loss of antigen presentation

Antibodies useful in cancer diagnosis

Coronavirus vaccine

Method for reducing immunogenicity of RNA

Therapeutic RNA

Antibodies specific for claudin 6 (CLDN6)

Antibodies for treatment of cancer expressing claudin 6

Combination therapy involving antibodies against claudin 18.2 for t...

Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (C...

Diagnosis and therapy of cancer involving cancer stem cells

Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2...

RNA constructs and uses thereof

Monoclonal antibodies against Claudin-18 for treatment of cancer

Methods and compositions for prediction of therapeutic efficacy of...

Patents Applicationslast 30 patents

METHODS AND COMPOSITIONS FOR PREDICTION OF THERAPEUTIC EFFICACY OF...

CHIMERIC ANTIGEN RECEPTOR-MODIFIED CELLS FOR THE TREATMENT OF CLDN6...

RNA ENCODING PEPTIDOGLYCAN HYDROLASE AND USE THEREOF FOR TREATING B...

AGENTS ENCODING CLDN6 AND CD3 BINDING ELEMENTS FOR TREATING CLDN6-P...

STABILIZATION OF POLY(A) SEQUENCE ENCODING DNA SEQUENCES

MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION...

TLR7 AGONIST AND COMBINATIONS FOR CANCER TREATMENT

THERAPEUTIC RNA FOR LUNG CANCER

MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION...

ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES TH...

RNA CONSTRUCTS AND USES THEREOF

VIRUS VACCINE

ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES TH...

CORONAVIRUS VACCINE

SYSTEMS AND METHODS FOR DETECTION, MONITORING, AND INTERACTIVE DISP...

TECHNOLOGIES FOR EARLY DETECTION OF VARIANTS OF INTEREST

THERAPEUTIC RNA FOR TREATING CANCER

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...

MULTISPECIFIC BINDING AGENTS AGAINST CD40 AND CD137 IN COMBINATION...

IMMUNOGEN SELECTION

ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS

RNA REPLICON FOR EXPRESSING AT CELL RECEPTOR OR AN ARTIFICIAL T CEL...

METHODS FOR CHARACTERIZING LOSS OF ANTIGEN PRESENTATION

COMBINATION DOSAGE REGIME OF CD137 AND PD-L1 BINDING AGENTS

AGONISTIC TNF RECEPTOR BINDING AGENTS

Agents for Treatment of Claudin Expressing Cancer Diseases

ANTIBODIES USEFUL IN CANCER DIAGNOSIS

Therapeutic RNA

BISPECIFIC TRIVALENT ANTIBODIES BINDING TO CLAUDIN6 OR CLAUDIN18.2...

MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER